UBS has initiated coverage on Sabra Health Care REIT Inc (SBRA) with a Neutral rating, marking the firm's first assessment of the company. This decision reflects UBS's analysis of the healthcare real estate investment trust's business, industry dynamics, and growth prospects.
Headquartered in Tustin, California, Sabra Health Care REIT engages in acquiring, financing, and owning real estate properties primarily leased to third-party operators in the healthcare sector. The company's investment portfolio includes skilled nursing facilities, senior housing communities, behavioral health facilities, and specialty hospitals, encompassing 37,047 beds/units across the United States and Canada.
As of November 17, 2025, SBRA's shares are trading at $18.81, with a market capitalization of $4.6 billion. The company has a P/E ratio of 26.48 and an impressive dividend yield of 645.5%. Upcoming earnings reports are anticipated on May 3, 2026, and August 2, 2026, with EPS estimates of $0.20 for both periods.
Analyst ratings serve as professional opinions derived from extensive research and financial modeling. They provide valuable insights but should be considered alongside company fundamentals and market conditions. The consensus among analysts regarding SBRA remains a Buy, with 5 Strong Buy, 6 Buy, 9 Hold, and no Sell ratings as of November 1, 2025. The recent action by UBS adds to the evolving landscape of analyst perspectives on the company.